Status:
COMPLETED
Prevalence and Burden of Bronchiectasis in Tuberculous Patients
Lead Sponsor:
Assiut University
Conditions:
Pulmonary Tuberculoses
Eligibility:
All Genders
18-50 years
Brief Summary
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment ...
Detailed Description
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment ...
Eligibility Criteria
Inclusion
- 1-patients were diagnosed to have tuberculosis by sputum culture and gene x pert.
- 2-patients were diagnosed to have bronchiectasis after lab and radiological examination as well as clinical score.
- 3- patients diagnosed as bronchiectasis after history of tuberculosis or anti Tuberculosis treatment with positive or negative tuberculous culture in the time of research.
Exclusion
- 1-patients presented with other Pulmonary diseases. 2-Chronic liver and renal disease . 3- Lung cancer and tumors. 4- patients were previously diagnosed as bronchiectasis .
Key Trial Info
Start Date :
September 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04085133
Start Date
September 26 2019
End Date
April 1 2020
Last Update
February 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut unviresty
Asyut, Egypt, 71511